Nanoparticle design characterized by in silico preparation parameter prediction using ensemble models

Journal of Pharmaceutical Sciences

Volumn 99, Issue 4, 2010, Pages 1982-1996

  Neumann, Dirk ^a   Merkwirth, Christian ^b   Lamprecht, Alf ^c,d  

^a SAARLAND UNIVERSITY   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Emulsification method; Linear and nonlinear ensemble models; Nanoparticle design; Nanoparticles; Prediction

Indexed keywords

ACETIC ACID ETHYL ESTER; DICHLOROMETHANE; EUDRAGIT RS; IBUPROFEN; NANOPARTICLE; POLYGLACTIN;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; PARTICLE SIZE; RESPONSE SURFACE METHOD; STATISTICAL MODEL; ZETA POTENTIAL;

EID: 77949782477     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21941     Document Type: Article

References (32)

1. Zhang X, Wiss UP, Pichora D, Goossen MF. 1994. A mechanistic study of antibiotic release from biodegradable poly(D,L-lactide) cylinders. J Control Release 31:128-144.
2. O'Hara P, Hickney AJ. 2000. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization. Pharm Res 17:955-961.
3. Kompella UB, Koushik K. 2001. Preparation of drug delivery systems using supercritical fluid technology. Crit Rev Ther Drug Carrier Syst 18:2173-2199.
4. O'Donnell PB, McGinity JW. 1997. Preparation of microspheres by the solvent evaporation technique. Adv Drug Del Rev 28:5-24.
5. Martinez-Sancho C, Herrero-Vanrell R, Negro S. 2004. Optimisation of aciclovir poly(D,L-lactide-coglycolide) microspheres for intravitreal administration using a factorial design study. Int J Pharm 273:45-56.
6. Molpeceres J, Guzman M, Aberturas MR, Chacon M, Berges L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J Pharm Sci 1996. 85:206-213.
7. Dillen K, Vandervoort J, Van den Mooter G, Verheyden L, Ludwig A. 2004. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 275:171-187.
8. Padamwar MN, Pokharkar VB. 2006. Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. Int J Pharm 320:37-44.
9. Coimbra PA, De Sousa HC, Gil MH. 2008. Preparation anc characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul 25:170-178.
10. Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Mirzadeh H, Fakhari A, Nokhodchi A. 2009. Particle design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. Int J Pharm 365:69-76.
11. Box GEP, Wilson KB. 1951. On the experimental attainment of optimum conditions. J R Stat Soc B 13:1-45.
12. Prakobvaitayakit M, Nimmannit U. 2003. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design. AAPS PharmSciTech 4:E71.
13. Derakhshandeh K, Erfan M, Dadashzadeh S. 2007. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics. Eur J Pharm Biopharm 66:34-41.
14. Bhavsar MD, Tiwari SB, Amiji MM. 2006. Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Control Release 110:422-430.
15. Dayhoff JE, DeLeo JM. 2001. Artifical neural networks. Opening the black box. Cancer Suppl 91: 1615-1635.
16. Rodvold DM, McLeod DG, Brandt JM, Snow PB, Murphy GP. 2001. Introduction to artificial neural networks: Taking the lid off the black box. Prostrate 46:39-44.
17. Wang X, Cui F, Yonezawa Y, Sunada H. 2003. Preparation and evaluation of high drug content particles. Drug Dev Ind Pharm 29:1109-1118.
18. Singh N, Seedat F, Pillay V, Sweet JL, Danckwerts MP. 2006. Formulation and statistical optimization of novel double-incorporated PLA-PLGA microparticles within an alginate-pectinate platform for the delivery of nicotine. J Microencapsul 23:153-167.
19. Arulsudar N, Subramanian N, Muthy RS. 2005. Comparison of artificial neural network and multiple linear regression in the optimization of formulation parameters of leuprolide acetate loaded liposomes. J Pharm Pharm Sci 8:243-258.
20. Svetnik V, Wang T, Tong C, Liaw A, Sheridan R, Song Q. 2005. Boosting: An ensemble learning tool for compound classification and QSAR modeling. J Chem Inf Model 45:786-799.
21. Arodz T, Yuen DA, Dudek AZ. 2006. Ensemle of linear models for predicting drug properties. J Chem Inf Model 46:416-423.
22. Votano J, Parham M, Hall L, Hall L, Kier L, Oloff S, Tropsha A. 2006. QSAR modeling pf human serum protein binding with several modeling techniques utilizing structure-information representation. J Med Chem 49:7169-7181.
23. Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Lehr CM, Maincent P, Kawashima Y. 2001. Design of rolipram loaded nanoparticles: Comparison of two preparation methods. J Control Release 71:297-306.
24. Lamprecht A, Saumet JL, Roux J, Benoit JP. 2004. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 278:407-414.
25. R Development Core Team, 2008. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
26. Neumann D, Kohlbacher O,Merkwirth C, Lengauer T. 2006. A fully computational model for predicting percutaneous drug absorption. J Chem Inf Model 4:424-429.
27. Breiman L. 1996. Bagging predictors. Mach Learn 24:123-140.
28. Alexandridou S, Kiparissides C. 1994. Production of oil-containing polyterephthalamide microcapsules by interfacial polymerization. An experimental investigation of the effect of process variables on the microcapsule size distribution. J Microencapsul 11:603-614.
29. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82:105-114.
30. Ubrich N, Schmidt C, Bodmeier R, Hoffman M, Maincent P. 2005. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Int J Pharm 288:169-175.
31. Arica B, Lamprecht A. 2005. In-vitro evaluation of betamethasone loaded nanoparticles. Drug Dev Ind Pharm 31:19-25.
32. Shah PP, Mashru RC, Thakkar AR, Badhan AC. 2008. Effect of chitosan crosslinking on bitterness of artemether using response surface methodology. J Pharm Pharmacol 60: 421-427.